In consideration of the high mutation frequency of Trp53 in BRCA1 deficient mammary tumors, and the much longer period for formation of Br53Ts than BrTs (Figure 1A), the mesenchymal like BrTs may generate and accumulate Trp53 mutation during the tumorigenesis process. The gene discussed is BRCA1; the disease is breast cancer.